1
Published 2020
Canadian Agency for Drugs and Technologies in Health
...Tafamidis (Vyndaqel) (Pfizer Canada ULC)...

2
Published 2020
CADTH
...Tafamidis (Vyndaqel) (Pfizer Canada ULC)...

3
Published 2020
Canadian Agency for Drugs and Technologies in Health
...Tafamidis (Vyndaqel) (Pfizer Canada ULC)...

4
Published 2019
Canadian Agency for Drugs and Technologies in Health
...Tofacitinib (Xeljanz) (Pfizer Canada Inc.)...

5
Published 2019
Canadian Agency for Drugs and Technologies in Health
...Tofacinitib (Xeljanz) (Pfizer Canada inc.)...

6
Published 2020
CADTH
...Tafamidis (Vyndaqel) (Pfizer Canada ULC)...

7
Published 2019
CADTH
...Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.)...

8
Published 2019
CADTH
...Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.)...

9
Published 2019
CADTH
...Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.)...

10
Published 2019
CADTH
...Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.)...

11
Published 2019
CADTH
...Crisaborole (Eucrisa -- Pfizer Canada Inc.)...

12
Published 2019
CADTH
...Crisaborole (Eucrisa -- Pfizer Canada Inc.)...

13
Published 2020
CADTH
...Tafamidis meglumine (Vyndaqel - Pfizer Canada ULC)...

14
Published 2020
CADTH
...Tafamidis meglumine (Vyndaqel - Pfizer Canada ULC)...

15
Published 2018
American Chemical Society

16
Published 2013
American Chemical Society

18
by González, Francisco Martínez
Published 2023
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...Pfizer vaccine...

19
Published 2013
Springer New York
Table of Contents: ...1.Forensic Epidemiology in the Global Context: A Case Study of Pfizer and the Trovafloxacin Trial...